8.1.1 Genomic and system-level approaches In the last two to three decades, NGS technologies have generated large amounts of omics data (genomics, transcriptomics, proteomics, epigenomics, and metabolomics), post-translational modification data (phosphorylation, SUMOylation, ubiquitinylation, etc.), single-cell, ATAC-Seq data and more, which provide a powerful lens for deciphering the molecular landscape of breast cancer (269)
Hyperoxia during cardiopulmonary bypass does not decrease cardiovascular complications following cardiac surgery: The CARDIOX randomized clinical trial
[7] [8] A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings
Consultation service led by Phlo Join our safe & supported weight loss service and increase your chance of sustained weight loss